9:48 AM
 | 
Mar 09, 2018
 |  BioCentury  |  Finance

Funding outbreak prevention

How CEPI plans to support vaccine development

After announcing its first-ever company agreement with Themis Bioscience GmbH, the Coalition for Epidemic Preparedness Innovations plans to unveil funding for more than 10 additional vaccine candidates by mid-year.

Since its January 2017 launch, CEPI has raised $630 million of a planned $1 billion to accelerate vaccine development for emerging infectious diseases.

Its first call for research proposals, issued last year, focused on vaccines against Lassa fever, Middle East respiratory syndrome (MERS) and Nipah virus. Those have been identified by the World Health Organization as high-priority...

Read the full 411 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >